SAN ANTONIO, March 30 /PRNewswire/ -- BioMedical Enterprises, Inc. (BME), a rapidly growing medical device company focused on the clinical development of orthopaedic memory metal implants, announced today that it has appointed Keith M. Peeples as its Vice President, Sales and Marketing.
BME specializes in nitinol implants that contract and compress bone after implantation, bringing bone ends together to promote bone union. The Orthopaedic Staple System (OSS)(TM) of proprietary staples and the patented OSSforce(TM) Controller allow the surgeon to finely control the amount of compression and rate of force application generated on bones, thereby reducing fractures and stimulate bone healing.
"Keith is a proven executive who brings extensive senior level sales and marketing experience to BME, as well as a shared strategic vision to create a leading medical device company," said Kenneth I. Moch, President and CEO of BME. "We are delighted to have Keith as part of our leadership team."
Mr. Peeples brings to BME over 25 years experience in sales, marketing and sales training in the healthcare industry. Prior to joining BME he was Vice President of Sales and Marketing at Advanced Bio-Surfaces, Inc., an orthopedic company that manufactures an interpositional knee implant system. From 1999 to 2006, Mr. Peeples was Vice President of Sales at The ASC Network, which offers a supply solution to physician owned or procedure based centers. From 1995-1998, Mr. Peeples was Director of Sales for North and South America at Medtronic / InStent, a provider of self-expanding nitinol stents for gastroenterology, urology, radiology and peripheral vascular procedures. Mr. Peeples also worked as the Western Regional Sales Manager and as an independent sales representative with Pentax Precision Instrument Corp., a provider of flexible endoscopes, from 1981 to 1995. Mr. Peeples has a B.A. in Biology from the
About BioMedical Enterprises, Inc.
BME designs, manufactures and markets memory metal implants used in orthopaedic reconstructive surgery and fracture management. BME's Orthopaedic Staple System (OSS)(TM) utilizes the unique properties of the shape memory alloy nitinol to provide controlled long-term compression that enhances the body's natural healing process in an effort to achieve faster healing times and fewer complications. BME's barbed and smooth OSStaple(TM) and Step OSStaple(TM) lines of bone fusion implants, along with the contoured OSSArc(TM), are designed to achieve controlled long-term compression of bone fragments. BME's OSSAnchor(TM) line of soft tissue fixation implants gives surgeons a simple yet powerful tool to attach soft tissue to bone. These implants are an integral part of BME's proprietary compression and fixation system activated by the patented OSSforce(TM) Implant Controller.
|SOURCE BioMedical Enterprises, Inc.|
Copyright©2009 PR Newswire.
All rights reserved